Bullpen.News From Edwin Dorsey
Get Daily Recap Feedback

Tuesday, October 27, 2026

Back to today

How to Read a 10-K Like a Short Seller

A four-layer 10-K framework tests revenue timing, receivables, reserves and depreciation against cash flow, using Hertz’s 2012-14 accounting as a case study.

HTZ $709M
Jimmy's Journal 68 clicks

From X

@StableBread 1 click

Fajasy on X

A solar manufacturer that grew revenue 141.5% in 2025 now trades at 2.0x TTM earnings, after falling 77.5% from its June peak. U.S. customs (CBP) has been detaining its Ethiopian cells since May, and Commerce is deciding whether they should pay the duties on Chinese cells, with a first ruling due around December 14. That company is TOYO Co., Ltd $TOYO, now at $3.83/share. $TOYO’s closest comps are four other listed solar manufacturers selling into the U.S., and all four are down from their 2026 highs too, as of the October 26 close: → First Solar $FSLR: Down 47.2% to $168.15/share. → Canadian Solar $CSIQ: Down 65.2% to $8.85/share. → JinkoSolar $JKS: Down 72.7% to $8.17/share. → T1 Energy $TE: Down 82.4% to $2.12/share. Only $TE has fallen further from its 2026 high. Besides CBP’s detentions and the Ethiopia inquiry, four more overhangs landed after the June peak: 1) Discounted stock sale: $TOYO sold $50M of stock and warrants at $11.00 on June 24, a 14.9% discount to the prior close, and the stock fell 38.8% that day to $7.91. 2) New tariff: An August 6 proclamation set a 15% U.S. tariff on imported solar cells and panels, including $TOYO’s cells from Ethiopia, starting December 4. 3) Guidance dropped: $TOYO didn’t reaffirm its 2026 targets with its H1 results on August 19, when the stock fell 24.2%, and on September 28 only said it expects positive EBITDA for H2 2026. 4) Parent delisted: The Tokyo Stock Exchange delisted Abalance, the Japanese group that controls $TOYO, on September 26. Still, $TOYO is profitable and has net cash: → Earnings: $156.4M of TTM EBITDA and $80.5M of TTM net income. → Cash flow: $61.4M from operations in H1 2026, less $27.8M of capex, for $33.7M of FCF. → Balance sheet: Went from a going-concern warning to positive working capital in six months, with $26.4M of net cash as of June 30. → Texas: Doubled its Texas module capacity to 2 GW and signed ~$240M of binding module contracts since mid-June. → Tax credits: Management expects $140M/year of U.S. manufacturing tax credits at full Texas output, 85.6% of $TOYO’s market cap, and leaves those credits out of its forecasts. $TOYO’s EV of $137.2M is just 0.9x its TTM EBITDA. So is $TOYO a profitable non-Chinese cell maker on sale, or is the market right that Ethiopia’s U.S. sales won’t last?
@aleabitoreddit 3 clicks

Serenity on X

I made a new “It’s All Over” portfolio today of even higher beta names than $AAOI. The requirements: 1. Fell off a cliff 2. Lower than when they announced their catalysts 3. Increasing fundamentals 4. Looks like the chart 5. Short interest spiking Stuff like $ALMU at $7, $CIFR at $8, $ASTS at $39, and some Leopold trades like $TE at $2.5, $SHAZ at $25. Not a recommendation, just curious how this performs into year end while doomposts are everywhere. Anyone got any other ones?
@stockgutter 1 click

SG on X

$ZURA Q3 report looked fine to me. All eyes awaiting H2 readout. Just bought this last week, covered by calls. Options premia were off the charts then and still are quite large (e.g. while the stock was trading 3.36, my net price for the portion I covered with Nov 5C was 2.46. Even less for the portion I covered w Mar 7.5C). I realize readout could occur before Nov expiry and the options reflect the risk of a bad readout. I'm comfortable taking that risk.

Investor Letters

All letters

Unicycive (UNCY):

Unicycive’s oxylanthanum carbonate NDA earned a March 25, 2027 PDUFA date after two manufacturing-related rejections, with no FDA clinical…

UNCY $104M
Triple S Special Situations Investing 4 clicks
BMBL 2026-10-21

Bumble is being taken private

Bumble agreed to a $6.05-per-share cash sale to Ithaca Holdings, 136% above its October 2 share price.

BMBL $788M
Modern Value Investing 8 clicks

GLOO, part two

Gloo faces related-party deals, insider-heavy IPO ownership, acquisition losses and $84.5 million of CEO-backed puts as it burns cash and…

GLOO $274M
Guardian Research 4 clicks

Carecloud News

CareCloud may attract a private-equity buyer after its Q3 call, with acquiring enough shares the main obstacle to a take-private deal.

CCLD $75M
Calvin Blissett 11 clicks

LXS.DE: a 2028 sale it can force

Lanxess can force Advent to buy at least half its Envalior stake in April 2028, potentially raising about €745 million to reduce net debt.

LPTH $578M
Trade Ideas Flow 21 clicks

Build-A-Bear: A Narrower Path

Build-A-Bear's push into prestuffed toys and broader retail distribution tests brand stretchability, but recent results warrant caution.

BBW $327M
TSOH Investment Research 18 clicks
SAMG · long

Silvercrest Asset Mgt

Silvercrest Asset Management is framed as undervalued while funding an ambitious investment cycle.

SAMG $82M
Value Investors Club

Twenty Years in the Dark

Tower Properties, $TPRP, went dark after a 2006 squeeze-out cut holders below 300, leaving a Kemper-controlled apartment and office…

TPRP $128M
Orphan REITs 6 clicks

TSOH Weekly Roundup (10/16/2026)

Bumble agreed to a $1.3 billion take-private deal, while Netflix cut about 1,000 jobs and Meta discussed its Muse superintelligence models.

BMBL $788M
TSOH Investment Research 12 clicks

Publications we follow

Every publication on this site, hand-picked.

129 publications

Newsletters 109

YouTube 4

Blogs 15

Seeking Alpha 67 of 266

Nominate a publication

X accounts we follow

Every account on this site, hand-picked.

91 accounts
Nominate an account

Investor letters we follow

190 firms

Sectors

Ordered by how often our editor reaches for them.